SENSEI, the first robotic gamma probe to be commercially available to European hospital systems, has received the CE Mark approval. The news was announced today. SENSEI has been designed for intra-operative detection of sentinel lymph nodes as well as cancer metastasis…
Occlutech, a Swiss-based privately-held company reported that the FDA has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) patients with preserved (HFpEF) or reduced (HFrEF) ejection fraction. Heart failure…
With the Pfizer BioNTech BNT162b2 vaccine and Moderna’s mRNA-1273 vaccine currently being administered to select groups, the buzz around the COVID-19 vaccine is palpable. Public response to the idea of a vaccine has also grown more favorable, with a national…
